Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Operating Expenses (2022 - 2025)

Historic Operating Expenses for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $2.3 million.

  • 60 Degrees Pharmaceuticals' Operating Expenses rose 748.36% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 1138.28%. This contributed to the annual value of $10.0 million for FY2024, which is 10292.48% up from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Operating Expenses is $2.3 million, which was up 748.36% from $1.9 million recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Operating Expenses' 5-year high stood at $4.2 million during Q2 2024, with a 5-year trough of $441282.0 in Q3 2022.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Operating Expenses averaged around $1.6 million, with its median value being $1.7 million (2023).
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Operating Expenses surged by 53373.26% in 2024, and later plummeted by 5591.25% in 2025.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Operating Expenses stood at $513022.0 in 2022, then soared by 249.03% to $1.8 million in 2023, then rose by 23.93% to $2.2 million in 2024, then increased by 4.38% to $2.3 million in 2025.
  • Its Operating Expenses stands at $2.3 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.1 million for Q1 2025.